Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
featured
Published in Dermatology

Journal Scan / Research · October 01, 2014

Risk for Non-Melanoma Skin Cancer During TNF-Inhibitor Treatment

Journal of the European Academy of Dermatology and Venereology: JEADV

 

 Save  Recommend
 Share

Additional Info

Journal of the European Academy of Dermatology and Venereology: JEADV
An Increased Risk of Non-Melanoma Skin Cancer During TNF-Inhibitor Treatment in Psoriasis Patients Compared to Rheumatoid Arthritis Patients Probably Relates to Disease-Related Factors
J Eur Acad Dermatol Venereol 2014 Sep 17;[EPub Ahead of Print], PP van Lümig, SP Menting, JM van den Reek, PI Spuls, PL van Riel, PC van de Kerkhof, J Fransen, W Kievit, EM de Jong

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated